The burden of presbyopia and reading glasses drives patients to look for solutions.“There is a clear and growing patient demand for noninvasive, reversible options to manage presbyopia,” Behnaz ...

The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...

Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore ...

The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...

Tenpoint Therapeutics announced FDA’s approval of Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% ...

YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...

The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, marking the first ...

Chu Vision, a leader in advanced eye care and vision correction, is addressing the growing demand for alternatives to reading glasses with a specialized procedure known as Monovision LASIK in an ...

Brinton Vision, a leader in advanced vision correction, announces groundbreaking solutions for individuals struggling with presbyopia, a common vision challenge faced by those over 40 in their article ...